Behavioral effects of SQSTM1/p62 overexpression in mice: Support for a mitochondrial role in depression and anxiety

Behavioural Brain Research

Volumn 248, Issue , 2013, Pages 94-103

  Seibenhener, M Lamar ^a   Zhao, Ting ^b   Du, Yifeng ^a   Calderilla Barbosa, Luis ^a   Yan, Jin ^a   Jiang, Jianxiong ^c   Wooten, Marie W ^a   Wooten, Michael C ^a  

^a AUBURN UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Affective spectrum disorder; Animal model; Anxiety; Depression; Mitochondria; SQSTM1 p62

Indexed keywords

CELL PROTEIN; PROTEIN P62; SEQUESTOSOME 1; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPRESSION; EMBRYO; FEMALE; FORCED SWIMMING TEST; GENE OVEREXPRESSION; LONG TERM MEMORY; MALE; MAZE TEST; MENTAL TASK; MITOCHONDRIAL ENERGY TRANSFER; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SPATIAL LEARNING; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; MUTATION; TRANSCRIPTION FACTORS;

EID: 84877153427     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.04.006     Document Type: Article

References (81)

1. Acevedo-Torres K., Berríos L., Rosario N., Dufault V., Skatchkov S., Eaton M.J., et al. Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. DNA Repair 2009, 8:126-136.
2. Ahn H.J., Hernandez C.M., Levenson J.M., Lubin F.D., Liou H.C., Sweatt J.D. c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learning and Memory 2008, 15:539-549.
3. Andreazza A.C., Shao L., Wang J.F., Young L.T. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Archives of General Psychiatry 2010, 67:360-368.
4. Barnes C.A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. Journal of Comparative and Physiological Psychology 1979, 93:74-104.
5. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Annals of Neurology 2005, 58:495-505.
6. Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. Journal of Cell Biology 2005, 171:603-614.
7. Calkins M.J., Manczak M., Mao P., Shirendeb U., Reddy P.H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Human Molecular Genetics 2011, 20:4515-4529.
8. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neuroscience and Biobehavioral Reviews 2005, 29:1193-1205.
9. Chamoux E., Couture J., Bisson M., Morissette J., Brown J.P., Roux S. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts. Molecular Endocrinology 2009, 23:1668-1680.
10. Ciani B., Layfield R., Cavey J.R., Sheppard P.W., Searle M.S. Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. Journal of Biological Chemistry 2003, 278:37409-37412.
11. Cryan J.F., Lucki I. Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. Journal of Pharmacology and Experimental Therapeutics 2000, 295:1120-1126.
12. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 2002, 23:238-245.
13. Curti C., Mingatto F.E., Polizello A.C., Galastri L.O., Uyemura S.A., Santos A.C. Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity. Molecular and Cellular Biochemistry 1999, 199:103-109.
14. Denis-Donini S., Dellarole A., Crociara P., Francese M.T., Bortolotto V., Quadrato G., et al. Impaired adult neurogenesis associated with short-term memory defects in NF-kappaB p50-deficient mice. Journal of Neuroscience 2008, 28:3911-3919.
15. Du Y., Wooten M.C., Gearing M., Wooten M.W. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radical Biology and Medicine 2009, 46:492-501.
16. Du Y., Wooten M.C., Wooten M.W. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease. Neurobiology of Disease 2009, 35:302-310.
17. Duran A., Linares J.F., Galvez A.S., Wikenheiser K., Flores J.M., Diaz-Meco M.T., et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008, 13:343-354.
18. Einat H., Yuan P., Manji H.K. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behavioural Brain Research 2005, 165:172-180.
19. Filiou M.D., Zhang Y., Teplytska L., Reckow S., Gormanns P., Maccarrone G., et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biological Psychiatry 2011, 70:1074-1082.
20. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:730-743.
21. Gardner A., Johansson A., Wibom R., Nennesmo I., von Döbeln U., Hagenfeldt L., et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. Journal of Affective Disorders 2003, 76:55-68.
22. Geetha T., Seibenhener M.L., Chen L., Madura K., Wooten M.W. p62 serves as a shuttling factor for TrkA interaction with the proteasome. Biochemical and Biophysical Research Communications 2008, 374:33-37.
23. Geisler S., Holmström K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biology 2010, 12:119-131.
24. Gensler S., Weber K., Schmitt W.E., Pérez-Martos A., Enriquez J.A., Montoya J., et al. Mechanism of mammalian mitochondrial DNA replication: import of mitochondrial transcription factor A into isolated mitochondria stimulates 7S DNA synthesis. Nucleic Acids Research 2001, 29:3657-3663.
25. Götz J., Chen F., Barmettler R., Nitsch R.M. Tau filament formation in transgenic mice expressing P301L tau. Journal of Biological Chemistry 2001, 276:529-534.
26. 1A receptors on learning and memory functions in rats. Neurochemical Research 2012, 37:2161-2166.
27. Harrison F.E., Hosseini A.H., MacDonald M.P. Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks. Behavioural Brain Research 2009, 198:247-251.
28. Hashimoto-Gotoh T., Iwabe N., Tsujimura A., Takao K., Miyakawa T. KF-1 ubiquitin ligase: an anxiety suppressor. Frontiers in Neuroscience 2009, 3:15-24.
29. Hayashi Y., Yoshida M., Yamato M., Ide T., Wu Z., Ochi-Shindou M., et al. Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. Journal of Neuroscience 2008, 28:8624-8634.
30. Hu T., Guan T., Gerace L. Molecular and functional characterization of the p62 complex, an assembly of nuclear pore complex glycoproteins. Journal of Cell Biology 1996, 134:589-601.
31. Huang C., Andres A.M., Ratliff E.P., Hernandez G., Lee P., Gottlieb R.A. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011, 6:e20975.
32. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988, 75:800-802.
33. Hoem J.M. The reporting of statistical significance in scientific journals. Demographic Research 2008, 18:437-442.
34. Jain A., Lamark T., Sjøttem E., Larsen K.B., Awuh J.A., Øvervatn A., et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. Journal of Biological Chemistry 2010, 285:22576-22591.
35. Jiang J., Parameshwaran K., Seibenhener M.L., Kang M.G., Suppiramaniam V., Huganir R.L., et al. AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. Hippocampus 2009, 19:392-406.
36. Jiang J., Suppiramaniam V., Wooten M.W. Posttranslational modifications and receptor-associated proteins in AMPA receptor trafficking and synaptic plasticity. Neuro-Signals 2006-2007, 15:266-282.
37. Kägi G., Klein C., Wood N.W., Schneider S.A., Pramstaller P.P., Tadic V., et al. Nonmotor symptoms in Parkin gene-related parkinsonism. Movement Disorders 2010, 25:1279-1284.
38. Kang D., Hamasaki N. Mitochondrial transcription factor A in the maintenance of mitochondrial DNA: overview of its multiple roles. Annals of the New York Academy of Sciences 2005, 1042:101-108.
39. Kang D., Kim S.H., Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 2007, 7:39-44.
40. Kanki T., Ohgaki K., Gaspari M., Gustafsson C.M., Fukuoh A., Sasaki N., et al. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Molecular and Cellular Biology 2004, 24:9823-9834.
41. Karry R., Klein E., Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biological Psychiatry 2004, 55:676-684.
42. Kasahara T., Kubota M., Miyauchi T., Noda Y., Mouri A., Nabeshima T., et al. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Molecular Psychiatry 2006, 11:577-593.
43. Kim S., Zhang S., Choi K.H., Reister R., Do C., Baykiz A.F., et al. An E3 ubiquitin ligase, Really Interesting New Gene (RING) Finger 41, is a candidate gene for anxiety-like behavior and beta-carboline-induced seizures. Biological Psychiatry 2009, 65:425-431.
44. Kirk R.E. Practical significance: a concept whose time has come. Educational and Psychological Measurement 1996, 56:746-759.
45. Kuusisto E., Salminen A., Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathology and Applied Neurobiology 2002, 28:228-237.
46. Lalonde R., Strazielle C. Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice. Journal of Neuroscience Methods 2008, 171:48-52.
47. Larsson N.G., Garman J.D., Oldfors A., Barsh G.S., Clayton D.A. A single mouse gene encodes the mitochondrial transcription factor A and a testis-specific nuclear HMG-box protein. Nature Genetics 1996, 13:296-302.
48. Laurin N., Brown J.P., Morissette J., Raymond V. Recurrent mutation of the gene encoding Sequestosome 1 (SQSTM1/p62) in Paget disease of bone. American Journal of Human Genetics 2002, 70:1582-1588.
49. Lee J.Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.P. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. Journal of Cell Biology 2010, 189:671-679.
50. Lee M., Shin J. Triage of oxidation-prone proteins by Sqstm1/p62 within the mitochondria. Biochemical and Biophysical Research Communications 2011, 413:122-127.
51. Lenaz G., Fato R., Castelluccio C., Cavazzoni M., Estornell E., Huertas J.F., et al. An updating of the biochemical function of coenzyme Q in mitochondria. Molecular Aspects of Medicine 1994, 15:s29-s36.
52. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behavioural Pharmacology 1997, 8:523-532.
53. Lucki I., Singh A., Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neuroscience and Biobehavioral Reviews 1994, 18:85-95.
54. Manfredi G., Kwong J.Q., Oca-Cossio J.A., Woischnik M., Gajewski C.D., Martushova K., et al. BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA. Journal of Biological Chemistry 2003, 278:5639-5645.
55. Manji H., Kato T., Di Prospero N.A., Ness S., Beal M.F., Krams M., et al. Impaired mitochondrial function in psychiatric disorders. Nature Reviews Neuroscience 2012, 13:293-307.
56. Manuel-Apolinar L., Meneses A. 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behavioural Brain Research 2004, 148:179-184.
57. Marazziti D., Baroni S., Picchetti M., Landi P., Silvestri S., Vatteroni E., et al. Mitochondrial alterations and neuropsychiatric disorders. Current Medicinal Chemistry 2011, 18:4715-4721.
58. Monteggia L.M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biological Psychiatry 2007, 61:187-197.
59. Murphy A.N., Bredesen D.E., Cortopassi G., Wang E., Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:9893-9898.
60. Ojuka E.O. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proceedings of the Nutrition Society 2004, 63:275-278.
61. Okatsu K., Saisho K., Shimanuki M., Nakada K., Shitara H., Sou Y.S., et al. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes to Cells 2010, 15:887-900.
62. Park I., Chung J., Walsh C.T., Yun Y., Strominger J.L., Shin J. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:12338-12342.
63. Piechal A., Blecharz-Klin K., Wyszogrodzka E., Kołomańska P., Rok-Bujko P., Krzaścik P., et al. Neonatal serotonin (5-HT) depletion does not affect spatial learning and memory in rats. Pharmacological Reports 2012, 64:266-274.
64. Ramesh Babu J., Lamar Seibenhener M., Peng J., Strom A.L., Kemppainen R., Cox N., et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. Journal of Neurochemistry 2008, 106:107-120.
65. Rea S.L., Walsh J.P., Ward L., Magno A.L., Ward B.K., Shaw B., et al. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding. Journal of Bone and Mineral Research 2009, 24:1216-1223.
66. Rocher C., Taanman J.W., Pierron D., Faustin B., Benard G., Rossignol R., et al. Influence of mitochondrial DNA level on cellular energy metabolism: implications for mitochondrial diseases. Journal of Bioenergetics and Biomembranes 2008, 40:59-67.
67. Rondi-Reig L., Lemaigre Dubreuil Y., Martinou J.C., Delhaye-Bouchaud N., Caston J., Mariani J. Fear decrease in transgenic mice overexpressing bcl-2 in neurons. NeuroReport 1997, 8:2429-2432.
68. Rosenfeldt F., Marasco S., Lyon W., Wowk M., Sheeran F., Bailey M., et al. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue. Journal of Thoracic and Cardiovascular Surgery 2005, 129:25-32.
69. Seibenhener M.L., Babu J.R., Geetha T., Wong H.C., Krishna N.R., Wooten M.W. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Molecular and Cellular Biology 2004, 24:8055-8068.
70. Seibenhener M.L., Du Y., Diaz-Meco M.T., Moscat J., Wooten M.C., Wooten MW A role for Sequestosome 1/p62 in mitochondrial dynamics, import and genome integrity. Biochimica et Biophysica Acta 2012, pii: S0167-4889(12)00325-4.
71. Seibenhener M.L., Wooten M.W. Isolation and culture of hippocampal neurons from prenatal mice. Journal of Visualized Experiments 2012, (65). pii: 3634. 10.3791/3634.
72. Shao C.Y., Crary J.F., Rao C., Sacktor T.C., Mirra S.S. Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies. Journal of Neuropathology and Experimental Neurology 2006, 65:327-335.
73. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behavioural Brain Research 1994, 61:59-64.
74. Suter M., Riek U., Tuerk R., Schlattner U., Wallimann T., Neumann D. Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. Journal of Biological Chemistry 2006, 281:32207-32216.
75. Thiffault C., Quirion R., Poirier J. The effect of l-deprenyl, d-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity. Brain Research. Molecular Brain Research 1997, 49:127-136.
76. Vadlamudi R.K., Joung I., Strominger J.L., Shin J. p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. Journal of Biological Chemistry 1996, 271:20235-20237.
77. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual Review of Genetics 2005, 39:359-407.
78. Wieckowski M.R., Giorgi C., Lebiedzinska M., Duszynski J., Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nature Protocols 2009, 4:1582-1590.
79. Woods S., Clarke N.N., Layfield R., Fone K.C. 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms. British Journal of Pharmacology 2012, 167:436-449.
80. Wooten M.W., Geetha T., Seibenhener M.L., Babu J.R., Diaz-Meco M.T., Moscat J. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. Journal of Biological Chemistry 2005, 280:35625-35629.
81. Yoshida Y., Izumi H., Ise T., Uramoto H., Torigoe T., Ishiguchi H., et al. Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA. Biochemical and Biophysical Research Communications 2002, 295:945-951.